CVD908delta-ssb-based SVN and MYCN vaccines (University of Maryland School of Medicine/Baylor College of Medicine)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCVD908delta-ssb-based SVN and MYCN vaccines (University of Maryland School of Medicine/Baylor College of Medicine)
Drug Alias Namecancer vaccine (University of Maryland School of Medicine/Baylor College of Medicine)CVD908ssb-TXSVNTXSVN
ClassificationVaccines > Development/production technology > Recombinant vector vaccineBiologics > Antigen > Tumor antigen
Mechanisms of ActionBaculoviral IAP repeat-containing protein 5 modulatorsN-myc proto-oncogene protein modulators
TargetsN-myc proto-oncogene proteinBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsMultiple MyelomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Maryland School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Maryland School of MedicineBaylor College Of Medicine
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A